$0.478
0.063[15.18%]
At close: Feb 7
Sio Gene Therapies Inc
(OTC:SIOX)Latest News for Sio Gene Therapies Inc Stock (OTC:SIOX)
Sio Gene Therapies Inc Stock (OTC: SIOX)
Categories: All
Thursday, February 09, 2023
Thursday, December 15, 2022
Wednesday, December 14, 2022
- On December 14, 2022, The Board Of Directors Of Sio Gene Therapies Unanimously Approved The Dissolution And Liquidation Of The Company Pursuant To A Plan Of Complete Liquidation And DissolutionBenzinga Newsdesk - Dec 14, 2022, 4:10PM
- Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 49 Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Dec 14, 2022, 2:04PM
Thursday, December 01, 2022
Thursday, November 10, 2022
Thursday, August 11, 2022
Tuesday, June 14, 2022
Wednesday, June 08, 2022
Tuesday, June 07, 2022
Wednesday, June 01, 2022
Friday, May 06, 2022
Wednesday, May 04, 2022
Friday, April 29, 2022
Thursday, April 28, 2022
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Apr 28, 2022, 3:31PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Apr 28, 2022, 3:18PM
- Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares PlummetLisa Levin - Apr 28, 2022, 3:17PM
- Mid-Day Market Update: Teladoc Health Drops Following Q1 Results; Swvl Holdings Shares JumpLisa Levin - Apr 28, 2022, 12:07PM
- 48 Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Apr 28, 2022, 12:05PM
- Sio Gene Therapies shares are trading lower after the company terminated its licensing agreement with the University of Massachusetts for the development and commercialization of GM1 and GM2 gene therapies.Michael Horton - Apr 28, 2022, 11:58AM
- Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022Benzinga Insights - Apr 28, 2022, 10:09AM
- HC Wainwright & Co. Downgrades Sio Gene Therapies to SellBenzinga Newsdesk - Apr 28, 2022, 8:56AM
- Sio Gene Therapies Ditches Two Remaining Programs, Seeks Buyer(s), Shares PlungeVandana Singh - Apr 28, 2022, 8:56AM
- The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma CandidatesVandana Singh - Apr 28, 2022, 8:52AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Apr 28, 2022, 8:16AM
- Cantor Fitzgerald Downgrades Sio Gene Therapies to Neutral, Announces $0.8 Price TargetBenzinga Newsdesk - Apr 28, 2022, 7:53AM
- 28 Stocks Moving in Thursday's Pre-Market SessionLisa Levin - Apr 28, 2022, 6:30AM
Wednesday, April 27, 2022
Tuesday, March 08, 2022
Tuesday, February 22, 2022
Friday, February 18, 2022
Monday, February 14, 2022
Friday, February 11, 2022
Wednesday, February 09, 2022
Sunday, February 06, 2022
Wednesday, February 02, 2022
Tuesday, February 01, 2022
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Feb 1, 2022, 1:20PM
- Sio Gene Therapies shares are trading lower after the company announced it terminated the AXO-Lenti-PD license agreement with Oxford Biomedica for Parkinson's disease and also announced a CEO transition.Benzinga Newsdesk - Feb 1, 2022, 12:38PM
- The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's ProgramShanthi Rexaline - Feb 1, 2022, 8:28AM
- HC Wainwright & Co. Maintains Buy on Sio Gene Therapies, Lowers Price Target to $7Benzinga Newsdesk - Feb 1, 2022, 8:22AM
- 10 Biggest Price Target Changes For TuesdayLisa Levin - Feb 1, 2022, 7:55AM
- SVB Leerink Downgrades Sio Gene Therapies to Market Perform, Lowers Price Target to $1Benzinga Newsdesk - Feb 1, 2022, 6:30AM
- Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO TransitionVandana Singh - Feb 1, 2022, 5:51AM